Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV95% of Ropivacaine for LSIB
NCT03329456Phase 4Completed
- Sponsor
- University Hospital of North Norway
- Start
- Oct 2017
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in Shoulder disorder, sponsored by University Hospital of North Norway. Started Oct 2017; status: completed.
02
Drugs
ropivacaine
03
Conditions
Shoulder disorder
Beyond the preview
Go deeper on NCT03329456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329456.